换一批摘要遗传性大疱性表皮松解症（EB）是一种罕见的残毁型、致死型单基因遗传性皮肤病，对社会和家庭造成了沉重负担。细胞疗法因其卓越稳定的临床疗效成为EB治疗中极有前景的一种手段，本文从干细胞和体细胞两方面总结近年来细胞疗法在EB的实验室研究及临床应用方面的进展。
更多相关知识
abstractsHereditary epidermolysis bullosa (EB) is a rare mutilating and lethal single-gene genodermatosis, and places a heavy burden on society and families. Cell therapy has become a very promising method for the treatment of EB due to its excellent and stable clinical efficacy. This review summarizes progress in laboratory research and clinical application of stem cell- and somatic cell-based therapies in EB in recent years.
More相关知识
关键词
大疱性表皮松解组织治疗干细胞组织工程皮肤单基因遗传性皮肤病Epidermolysis bullosaTissue therapyStem cellsTissue-engineered skinSingle-gene genodermatosis
栏目名称
DOI
10.35541/cjd.20201116
发布时间
2023-07-15（万方平台首次上网日期，不代表论文的发表时间）
- 浏览81
- 被引2
- 下载5
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
